Kailera Therapeutics to share updates on Phase 3 weight-loss drug

Kailera Therapeutics, listed on Nasdaq as KLRA and based in Waltham, Massachusetts, will present at the 2026 Jefferies Global Healthcare Conference on Thursday, June 4, with Ron Renaud, president and chief executive officer, scheduled to speak at 10:30 a.m. EDT. A live webcast will be available on the events page of the company’s investor website […] The post Kailera Therapeutics to share updates on Phase 3 weight-loss drug appeared first on Longevity.Technology.